Insider Trading in U.S. Stocks | Kenvue disclosed four insider transactions on March 12

2026-04-09 12:57:36

On March 12, 2026, Kenvue (KVUE) disclosed four insider trading transactions. Executive Stevens Meredith sold 1,738 shares on March 10, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 12, 2026	Executive	Stevens Meredith	March 10, 2026	Sell	358	18.16	6,501.28
March 12, 2026	Executive	Stevens Meredith	March 10, 2026	Sell	1,738	17.96	$31.2k
March 12, 2026	Executive	Alvarado Luani	March 10, 2026	Sell	357	18.16	6,483.12
March 12, 2026	Executive	Alvarado Luani	March 10, 2026	Sell	1,721	17.96	$30.9k
March 9, 2026	Executive	Stevens Meredith	March 5, 2026	Sell	1,677	18.25	$30.6k
March 9, 2026	Executive	Howlett Heather	March 5, 2026	Sell	933	18.25	$17k
March 9, 2026	Executive	Alvarado Luani	March 5, 2026	Sell	2,094	18.25	$38.2k
March 4, 2026	Executive	Howlett Heather	March 3, 2026	Sell	526	18.15	$9,546.90
February 18, 2026	Executive	Lawson Carlton	February 13, 2026	Buy	34.9k	18.66	$651.4k
February 18, 2026	Executive	Stevens Meredith	February 13, 2026	Sell	8,031	18.66	$149.9k

【Company Information】

Kenvue Inc. was incorporated in Delaware on February 23, 2022. The company is the world’s largest pure consumer health company. It aims to achieve sustainable profit growth by providing innovative products, solutions, and experiences supported by science, centered on consumer health. Their operations span over 165 countries worldwide, with a history of more than 135 years, positioning them as a global leader at the intersection of healthcare and consumer goods.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.